BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Medicamen Organics Ltd. Share Price

NSE
BSE

NSE : MEDIORG

BSE : 0

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

₹22.25

High

₹22.25

Price Summary

Previous Close ₹22.25
Day's Range ₹22.25 - ₹22.25
Open ₹22.25
52 Week Range ₹19.10 - ₹45.00
Volume 2,000
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 0.45
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 0.00
TTM EPS (₹) -3.30
P/E Ratio 6.27
Book Value(₹) 0.90
PAT Margin (%) 10.60
Face Value (₹) 10.00
ROCE(%) 16.97

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales N/A 370.88
Expenses N/A N/A
PBT N/A 43.87
Operating profit N/A 0.0
Net profit N/A 32.71

Shareholding Pattern

Promoters (% Holding)

59.73%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

38.56%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.07%

About Medicamen Organics Ltd.

Founded 1995
Managing Director Bal Kishan Gupta
NSE Symbol MEDIORG

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,65,195.06 1,935.25 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 1,80,822.60 6,832.30 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,65,724.89 4,895.20 3,309.40 - 3,309.40
Apollo Hospitals Enterprise Ltd. 1,27,148.05 8,843.70 6,696.50 - 6,696.50
Cipla Ltd. 1,16,467.06 1,438.75 1,165.70 - 1,165.70
Zydus Lifesciences Ltd. 1,15,695.48 1,150.50 835.50 - 835.50
Lupin Ltd. 1,14,441.32 2,496.90 1,836.80 - 1,836.80
Max Healthcare Institute Ltd. 1,07,147.67 1,108.15 903.00 - 903.00
Dr. Reddy's Laboratories Ltd. 1,05,987.13 1,245.50 1,148.40 - 1,148.40
Mankind Pharma Ltd. 1,04,543.74 2,526.55 1,909.70 - 1,909.70
no-content No Records Found

Latest News

Jul
10
2026
EQUITY Posted on Jul 10th 2026

Makers Laboratories informs about annual report

Makers Laboratories has informed that it enclosed copy of Annual Report for the financial year ended 31st March, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Jul
10
2026
EQUITY Posted on Jul 10th 2026

Mankind Pharma informs about certificate

Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, Mankind Pharmahas informed that it enclosed a copy of the certificate received from KFin Technologies, the Registrar and Share Transfer Agent of the Company for the quarter ended on June 30, 2026. 
The above information is a part of company’s filings submitted to BSE.
Read More
Jul
10
2026
EQUITY Posted on Jul 10th 2026

Mankind Pharma informs about newspaper advertisement

Mankind Pharma has informed that it enclosed copies of the newspaper advertisement published in ‘Financial Express’ (English) and ‘Jansatta’ (Hindi) on July 10, 2026 regarding 35th AGM of the Company scheduled to be held on Tuesday, August 4, 2026 through Video Conferencing / Other Audio-Visual Means and information relating to e-voting.
The above information is a part of company’s filings submitted to BSE.
Read More
Jul
10
2026
EQUITY Posted on Jul 10th 2026

Corona Remedies informs about AGM proceedings

Corona Remedies has informed that Annual General Meeting (AGM) of the Company was held on Thursday, July 09, 2026 through Video Conferencing / Other Audio Visual Means. The following resolutions as mentioned in the Notice of the 22nd AGM were passed through remote e-voting: To receive, consider and adopt the Audited Financial Statements (Standalone and Consolidated) of the Company for the financial year ended March 31, 2026 and the Reports of the Board of Directors and Auditors thereon for the financial year ended March 31, 2026; To declare final dividend of ₹10 each (Rupees Ten each) (100%) per Equity Share having face value of ₹10 each for the FY2025-26; To appoint a Director in place of Nirav Mehta (DIN: 01644041), who retires by rotation and being eligible, offers himself for re-appointment;. To appoint Walker Chandiok & Co LLP, Chartered Accountants, as the Statutory Auditors of the Company and to fix their remuneration; To ratify the remuneration payable to the Cost Auditors for the FY2026-27; To appoint Dhara Patel, Company Secretary Firm as Secretarial Auditors of the Company; To approve payment of commission to the Non Executive Directors of the Company; To approve payment of remuneration to Dr. Kirtikumar Mehta (DIN: 00385658), Non Executive Director and Chairman of the Company for the Financial Year 2026-27; Re-appointment of Dr. Kirtikumar Mehta (DIN: 00385658) as Non Executive Director and Chairman of the Company for a term of 5 years.
The above information is a part of company’s filings submitted to BSE.
Read More
Jul
10
2026
EQUITY Posted on Jul 10th 2026

Dr. Reddy’s Laboratories informs about audio recording of conference call

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Reddy’s Laboratories has informed that it enclosed the link of the audio recording of the conference call, conducted on July 9, 2026. 
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Medicamen Organics Ltd. ?

The current share price of Medicamen Organics Ltd. is ₹22.25 as of 2026-07-10.

The market capitalisation of Medicamen Organics Ltd. is ₹27.01 as of 2026-07-09.

The 1-year return of Medicamen Organics Ltd. is -19.35% as of 2026-07-10.

The P/E ratio of Medicamen Organics Ltd. is 6.27 as of 2026-07-10.

The 52-week high and low of Medicamen Organics Ltd. are ₹45.00 and ₹19.10, respectively, as of 2026-07-10.

The dividend yield of Medicamen Organics Ltd. is 0.0% as of2026-07-09.

You can buy Medicamen Organics Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Medicamen Organics Ltd. is Bal Kishan Gupta.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore